New York A09217 protects mifepristone and medication abortion drugs from criminal and regulatory penalties under certain conditions.

New York A09217 amends the penal law to ensure that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion is not considered a criminal conversion act if the drug was accurately labeled at the time of manufacture and is recommended for its intended use under current World Health Organization guidelines. Additionally, the bill amends the education law to prevent mifepristone or any drug used for medication abortion from being deemed adulterated or misbranded solely because it is no longer approved or bears a different label, provided the same.

New York A09217 protects mifepristone and medication abortion drugs from criminal and regulatory penalties under certain conditions.

New York A09217 amends the penal law to ensure that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion is not considered a criminal conversion act if the drug was accurately labeled at the time of manufacture and is recommended for its intended use under current World Health Organization guidelines. Additionally, the bill amends the education law to prevent mifepristone or any drug used for medication abortion from being deemed adulterated or misbranded solely because it is no longer approved or bears a different label, provided the same.